Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 14, 2026 Filed Apr 16, 2026 19:29 UTC |
Sloane Stanton DDirector
|
Exercise / conversionCACI Common Stock | 84 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-025466 · wk-form4_1776367762.xml · nonDerivative · entry 1 Sloane Stanton D · CIK 0001291899 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On October 17, 2025, Stanton D Sloane, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 20:29 UTC |
Plunkett Debora ADirector
|
SaleCACI Common Stock | 220 | $603.30 | $132,726.00 |
DisclosureSEC source: 0001628280-26-017290 · wk-form4_1773347341.xml · nonDerivative · entry 1 Plunkett Debora A · CIK 0001699997 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,428 Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 14:56 UTC |
Koegel J William JREVP, General Counsel
|
SaleCACI Common Stock | 2,000 | $615.06 | $1,230,125.00 |
DisclosureSEC source: 0001604478-26-000002 · wk-form4_1770908214.xml · nonDerivative · entry 1 Koegel J William JR · CIK 0001604478 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,931 Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 19:44 UTC |
DISBROW LISA SDirector
|
GrantCACI Common Stock | 44 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-002341 · wk-form4_1768592669.xml · nonDerivative · entry 2 DISBROW LISA S · CIK 0001712360 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,154 F2 · price: Ms. Disbrow was granted 44 shares of common stock on January 15, 2026 in connection with her annual retainer as Chair of the Board. Read SEC document |
| January 14, 2026 Filed Jan 16, 2026 19:45 UTC |
Nolan Philip ODirector
|
Exercise / conversionRestricted Stock Units · Derivative | 84 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-002346 · wk-form4_1768592702.xml · derivative · entry 2 Nolan Philip O · CIK 0001369304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254 Underlying: CACI Common Stock · 84 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On October 17, 2025, Philip O. Nolan, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · price: On October 17, 2025, Philip O. Nolan, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.exercise_date: On October 17, 2025, Philip O. Nolan, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.expiration_date: On October 17, 2025, Philip O. Nolan, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| January 14, 2026 Filed Jan 16, 2026 19:45 UTC |
Nolan Philip ODirector
|
Exercise / conversionCACI Common Stock | 84 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-002346 · wk-form4_1768592702.xml · nonDerivative · entry 1 Nolan Philip O · CIK 0001369304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,153 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On October 17, 2025, Philip O. Nolan, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| January 14, 2026 Filed Jan 16, 2026 19:44 UTC |
SZEWS CHARLES LDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 84 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-002345 · wk-form4_1768592696.xml · derivative · entry 2 SZEWS CHARLES L · CIK 0001230604 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254 Underlying: CACI Common Stock · 84 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On October 17, 2025,Mr. Szews was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · price: On October 17, 2025,Mr. Szews was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.exercise_date: On October 17, 2025,Mr. Szews was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.expiration_date: On October 17, 2025,Mr. Szews was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| January 14, 2026 Filed Jan 16, 2026 19:44 UTC |
SZEWS CHARLES LDirector
|
Exercise / conversionCACI Common Stock | 84 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-002345 · wk-form4_1768592696.xml · nonDerivative · entry 1 SZEWS CHARLES L · CIK 0001230604 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 415 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On October 17, 2025,Mr. Szews was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| January 14, 2026 Filed Jan 16, 2026 19:44 UTC |
Gordon Susan M.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 84 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-002343 · wk-form4_1768592683.xml · derivative · entry 2 Gordon Susan M. · CIK 0001809523 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254 Underlying: CACI Common Stock · 84 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On October 17, 2025, Susan M. Gordon was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026,85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · price: On October 17, 2025, Susan M. Gordon was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026,85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.exercise_date: On October 17, 2025, Susan M. Gordon was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026,85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.expiration_date: On October 17, 2025, Susan M. Gordon was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026,85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| January 14, 2026 Filed Jan 16, 2026 19:44 UTC |
Gordon Susan M.Director
|
Exercise / conversionCACI Common Stock | 84 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-002343 · wk-form4_1768592683.xml · nonDerivative · entry 1 Gordon Susan M. · CIK 0001809523 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,821 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On October 17, 2025, Susan M. Gordon was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026,85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| January 14, 2026 Filed Jan 16, 2026 19:44 UTC |
MORRISON SCOTT CDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 84 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-002344 · wk-form4_1768592690.xml · derivative · entry 2 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254 Underlying: CACI Common Stock · 84 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On October 17, 2025,Scott C .Morrison, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · price: On October 17, 2025,Scott C .Morrison, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.exercise_date: On October 17, 2025,Scott C .Morrison, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.expiration_date: On October 17, 2025,Scott C .Morrison, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| January 14, 2026 Filed Jan 16, 2026 19:44 UTC |
MORRISON SCOTT CDirector
|
Exercise / conversionCACI Common Stock | 84 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-002344 · wk-form4_1768592690.xml · nonDerivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 415 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On October 17, 2025,Scott C .Morrison, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| January 14, 2026 Filed Jan 16, 2026 19:44 UTC |
Sloane Stanton DDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 84 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-002342 · wk-form4_1768592677.xml · derivative · entry 2 Sloane Stanton D · CIK 0001291899 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254 Underlying: CACI Common Stock · 84 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On October 17, 2025, Stanton D Sloane, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · price: On October 17, 2025, Stanton D Sloane, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.exercise_date: On October 17, 2025, Stanton D Sloane, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.expiration_date: On October 17, 2025, Stanton D Sloane, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| January 14, 2026 Filed Jan 16, 2026 19:44 UTC |
Sloane Stanton DDirector
|
Exercise / conversionCACI Common Stock | 84 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-002342 · wk-form4_1768592677.xml · nonDerivative · entry 1 Sloane Stanton D · CIK 0001291899 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 943 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On October 17, 2025, Stanton D Sloane, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| January 14, 2026 Filed Jan 16, 2026 19:44 UTC |
DISBROW LISA SDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 123 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-002341 · wk-form4_1768592669.xml · derivative · entry 3 DISBROW LISA S · CIK 0001712360 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 369 Underlying: CACI Common Stock · 123 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On October 16, 2025 Ms. Disbrow. was granted 492 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 123 shares will vest on January 14, 2026, 123 shares on April 14, 2026, 123 shares on July 13, 2026 and 123 shares on October 11, 2026. F1 · price: On October 16, 2025 Ms. Disbrow. was granted 492 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 123 shares will vest on January 14, 2026, 123 shares on April 14, 2026, 123 shares on July 13, 2026 and 123 shares on October 11, 2026. F1 · derivative.exercise_date: On October 16, 2025 Ms. Disbrow. was granted 492 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 123 shares will vest on January 14, 2026, 123 shares on April 14, 2026, 123 shares on July 13, 2026 and 123 shares on October 11, 2026. F1 · derivative.expiration_date: On October 16, 2025 Ms. Disbrow. was granted 492 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 123 shares will vest on January 14, 2026, 123 shares on April 14, 2026, 123 shares on July 13, 2026 and 123 shares on October 11, 2026. Read SEC document |
| January 14, 2026 Filed Jan 16, 2026 19:44 UTC |
DISBROW LISA SDirector
|
Exercise / conversionCACI Common Stock | 123 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-002341 · wk-form4_1768592669.xml · nonDerivative · entry 1 DISBROW LISA S · CIK 0001712360 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,110 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On October 16, 2025 Ms. Disbrow. was granted 492 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 123 shares will vest on January 14, 2026, 123 shares on April 14, 2026, 123 shares on July 13, 2026 and 123 shares on October 11, 2026. Read SEC document |
| January 14, 2026 Filed Jan 16, 2026 19:44 UTC |
Plunkett Debora ADirector
|
Exercise / conversionRestricted Stock Units · Derivative | 84 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-002340 · wk-form4_1768592661.xml · derivative · entry 2 Plunkett Debora A · CIK 0001699997 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254 Underlying: CACI Common Stock · 84 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On October 17, 2025, Debora A. Plunkett, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · price: On October 17, 2025, Debora A. Plunkett, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.exercise_date: On October 17, 2025, Debora A. Plunkett, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.expiration_date: On October 17, 2025, Debora A. Plunkett, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| January 14, 2026 Filed Jan 16, 2026 19:44 UTC |
Plunkett Debora ADirector
|
Exercise / conversionCACI Common Stock | 84 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-002340 · wk-form4_1768592661.xml · nonDerivative · entry 1 Plunkett Debora A · CIK 0001699997 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,648 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On October 17, 2025, Debora A. Plunkett, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| January 14, 2026 Filed Jan 16, 2026 19:44 UTC |
McCarthy Ryan DDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 84 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-002339 · wk-form4_1768592653.xml · derivative · entry 2 McCarthy Ryan D · CIK 0001895585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254 Underlying: CACI Common Stock · 84 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On October 17, 2025, Ryan D. McCarthy, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · price: On October 17, 2025, Ryan D. McCarthy, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.exercise_date: On October 17, 2025, Ryan D. McCarthy, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.expiration_date: On October 17, 2025, Ryan D. McCarthy, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| January 14, 2026 Filed Jan 16, 2026 19:44 UTC |
McCarthy Ryan DDirector
|
Exercise / conversionCACI Common Stock | 84 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-002339 · wk-form4_1768592653.xml · nonDerivative · entry 1 McCarthy Ryan D · CIK 0001895585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,153 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On October 17, 2025, Ryan D. McCarthy, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 20:47 UTC |
JEWS WILLIAM LDirector
|
SaleCACI Common Stock | 3,000 | $585.82 | $1,757,460.00 |
DisclosureSEC source: 0001628280-25-056736 · wk-form4_1765572472.xml · nonDerivative · entry 1 JEWS WILLIAM L · CIK 0001107218 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,384 Read SEC document |
| November 01, 2025 Filed Nov 4, 2025 21:12 UTC |
MACLAUCHLAN JEFFREY DChief Financial Officer
|
Exercise / conversionPerformance Restricted Stock Units · Derivative | 5,072 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-048836 · wk-form4_1762290719.xml · derivative · entry 6 MACLAUCHLAN JEFFREY D · CIK 0001633580 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: CACI Common Stock · 5,072 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: On November 1, 2022, Mr. MacLauchlan was granted 3,302 performance restricted stock units. The PRSU's vested on the third anniversary of the grant date based on the achievement of a three-year performance measure. F2 · price: On November 1, 2022, Mr. MacLauchlan was granted 3,302 performance restricted stock units. The PRSU's vested on the third anniversary of the grant date based on the achievement of a three-year performance measure. F2 · derivative.exercise_date: On November 1, 2022, Mr. MacLauchlan was granted 3,302 performance restricted stock units. The PRSU's vested on the third anniversary of the grant date based on the achievement of a three-year performance measure. F2 · derivative.expiration_date: On November 1, 2022, Mr. MacLauchlan was granted 3,302 performance restricted stock units. The PRSU's vested on the third anniversary of the grant date based on the achievement of a three-year performance measure. Read SEC document |
| November 01, 2025 Filed Nov 4, 2025 21:12 UTC |
MACLAUCHLAN JEFFREY DChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,101 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-048836 · wk-form4_1762290719.xml · derivative · entry 5 MACLAUCHLAN JEFFREY D · CIK 0001633580 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: CACI Common Stock · 1,101 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On November 1, 2022, Mr. MacLauchlan was granted 3,301 restricted stock units. The restricted stock units vest 1/3 per year for 3 years. F1 · price: On November 1, 2022, Mr. MacLauchlan was granted 3,301 restricted stock units. The restricted stock units vest 1/3 per year for 3 years. F1 · derivative.exercise_date: On November 1, 2022, Mr. MacLauchlan was granted 3,301 restricted stock units. The restricted stock units vest 1/3 per year for 3 years. F1 · derivative.expiration_date: On November 1, 2022, Mr. MacLauchlan was granted 3,301 restricted stock units. The restricted stock units vest 1/3 per year for 3 years. Read SEC document |
| November 01, 2025 Filed Nov 4, 2025 21:12 UTC |
MACLAUCHLAN JEFFREY DChief Financial Officer
|
Tax withholdingCACI Common Stock | 2,488 | $562.25 | $1,398,878.00 |
DisclosureSEC source: 0001628280-25-048836 · wk-form4_1762290719.xml · nonDerivative · entry 4 MACLAUCHLAN JEFFREY D · CIK 0001633580 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,475 Read SEC document |
| November 01, 2025 Filed Nov 4, 2025 21:12 UTC |
MACLAUCHLAN JEFFREY DChief Financial Officer
|
Exercise / conversionCACI Common Stock | 5,072 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-048836 · wk-form4_1762290719.xml · nonDerivative · entry 3 MACLAUCHLAN JEFFREY D · CIK 0001633580 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,963 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: On November 1, 2022, Mr. MacLauchlan was granted 3,302 performance restricted stock units. The PRSU's vested on the third anniversary of the grant date based on the achievement of a three-year performance measure. Read SEC document |
| November 01, 2025 Filed Nov 4, 2025 21:12 UTC |
MACLAUCHLAN JEFFREY DChief Financial Officer
|
Tax withholdingCACI Common Stock | 541 | $562.25 | $304,177.25 |
DisclosureSEC source: 0001628280-25-048836 · wk-form4_1762290719.xml · nonDerivative · entry 2 MACLAUCHLAN JEFFREY D · CIK 0001633580 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,891 Read SEC document |
| November 01, 2025 Filed Nov 4, 2025 21:12 UTC |
MACLAUCHLAN JEFFREY DChief Financial Officer
|
Exercise / conversionCACI Common Stock | 1,101 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-048836 · wk-form4_1762290719.xml · nonDerivative · entry 1 MACLAUCHLAN JEFFREY D · CIK 0001633580 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,432 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On November 1, 2022, Mr. MacLauchlan was granted 3,301 restricted stock units. The restricted stock units vest 1/3 per year for 3 years. Read SEC document |
| October 16, 2025 Filed Oct 20, 2025 21:31 UTC |
Blazer EricSVP, Corp. Controller & CAO
|
Exercise / conversionRestricted Stock Units · Derivative | 98 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001997961-25-000008 · wk-form4_1760995888.xml · derivative · entry 3 Blazer Eric · CIK 0001997961 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99 Underlying: CACI Common Stock · 98 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On October 16, 2023, Mr. Blazer was granted 294 restricted stock units. These restricted stock units vest 1/3 per year for three years. F1 · price: On October 16, 2023, Mr. Blazer was granted 294 restricted stock units. These restricted stock units vest 1/3 per year for three years. F1 · derivative.exercise_date: On October 16, 2023, Mr. Blazer was granted 294 restricted stock units. These restricted stock units vest 1/3 per year for three years. F1 · derivative.expiration_date: On October 16, 2023, Mr. Blazer was granted 294 restricted stock units. These restricted stock units vest 1/3 per year for three years. Read SEC document |
| October 16, 2025 Filed Oct 20, 2025 21:31 UTC |
Blazer EricSVP, Corp. Controller & CAO
|
Tax withholdingCACI Common Stock | 30 | $518.23 | $15,546.90 |
DisclosureSEC source: 0001997961-25-000008 · wk-form4_1760995888.xml · nonDerivative · entry 2 Blazer Eric · CIK 0001997961 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180 Read SEC document |
| October 16, 2025 Filed Oct 20, 2025 21:31 UTC |
Blazer EricSVP, Corp. Controller & CAO
|
Exercise / conversionCACI Common Stock | 98 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001997961-25-000008 · wk-form4_1760995888.xml · nonDerivative · entry 1 Blazer Eric · CIK 0001997961 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On October 16, 2023, Mr. Blazer was granted 294 restricted stock units. These restricted stock units vest 1/3 per year for three years. Read SEC document |
| October 16, 2025 Filed Oct 20, 2025 21:31 UTC |
MORRISON SCOTT CDirector
|
GrantRestricted Stock Units · Derivative | 338 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001205945-25-000006 · wk-form4_1760995894.xml · derivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338 Underlying: CACI Common Stock · 338 shares Expires not disclosed F1 · derivative.exercise_price: On October 16, 2025, Mr. Morrison was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · price: On October 16, 2025, Mr. Morrison was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.exercise_date: On October 16, 2025, Mr. Morrison was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.expiration_date: On October 16, 2025, Mr. Morrison was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| October 16, 2025 Filed Oct 20, 2025 21:31 UTC |
JEWS WILLIAM LDirector
|
GrantRestricted Stock Units · Derivative | 338 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001107218-25-000007 · wk-form4_1760995882.xml · derivative · entry 1 JEWS WILLIAM L · CIK 0001107218 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338 Underlying: CACI Common Stock · 338 shares Expires not disclosed F1 · derivative.exercise_price: On October 16, 2025, Mr. Jews was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · price: On October 16, 2025, Mr. Jews was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.exercise_date: On October 16, 2025, Mr. Jews was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.expiration_date: On October 16, 2025, Mr. Jews was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| October 16, 2025 Filed Oct 20, 2025 21:31 UTC |
Plunkett Debora ADirector
|
GrantRestricted Stock Units · Derivative | 338 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001699997-25-000005 · wk-form4_1760995875.xml · derivative · entry 1 Plunkett Debora A · CIK 0001699997 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338 Underlying: CACI Common Stock · 338 shares Expires not disclosed F1 · derivative.exercise_price: On October 16, 2025, Ms. Plunkett was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · price: On October 16, 2025, Ms. Plunkett was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.exercise_date: On October 16, 2025, Ms. Plunkett was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.expiration_date: On October 16, 2025, Ms. Plunkett was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| October 16, 2025 Filed Oct 20, 2025 21:31 UTC |
Gordon Susan M.Director
|
GrantRestricted Stock Units · Derivative | 338 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809523-25-000011 · wk-form4_1760995869.xml · derivative · entry 1 Gordon Susan M. · CIK 0001809523 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338 Underlying: CACI Common Stock · 338 shares Expires not disclosed F1 · derivative.exercise_price: On October 16, 2025, Ms. Gordon was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026,85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · price: On October 16, 2025, Ms. Gordon was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026,85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.exercise_date: On October 16, 2025, Ms. Gordon was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026,85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.expiration_date: On October 16, 2025, Ms. Gordon was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026,85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| October 16, 2025 Filed Oct 20, 2025 21:30 UTC |
DISBROW LISA SDirector
|
GrantRestricted Stock Units · Derivative | 492 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001712360-25-000005 · wk-form4_1760995855.xml · derivative · entry 2 DISBROW LISA S · CIK 0001712360 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 492 Underlying: CACI Common Stock · 492 shares Expires not disclosed F2 · derivative.exercise_price: On October 16, 2025, Ms. Disbrow was granted 492 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 123 shares will vest on January 14, 2026, 123 shares on April 14, 2026, 123 shares on July 13, 2026 and 123 shares on October 11, 2026. F2 · price: On October 16, 2025, Ms. Disbrow was granted 492 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 123 shares will vest on January 14, 2026, 123 shares on April 14, 2026, 123 shares on July 13, 2026 and 123 shares on October 11, 2026. F2 · derivative.exercise_date: On October 16, 2025, Ms. Disbrow was granted 492 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 123 shares will vest on January 14, 2026, 123 shares on April 14, 2026, 123 shares on July 13, 2026 and 123 shares on October 11, 2026. F2 · derivative.expiration_date: On October 16, 2025, Ms. Disbrow was granted 492 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 123 shares will vest on January 14, 2026, 123 shares on April 14, 2026, 123 shares on July 13, 2026 and 123 shares on October 11, 2026. Read SEC document |
| October 16, 2025 Filed Oct 20, 2025 21:30 UTC |
DISBROW LISA SDirector
|
GrantCACI Common Stock | 53 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001712360-25-000005 · wk-form4_1760995855.xml · nonDerivative · entry 1 DISBROW LISA S · CIK 0001712360 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,987 F1 · price: Ms. Disbrow was granted 53 shares of common stock on October 16, 2025 in connection with her annual retainer as Chair of the Board. Read SEC document |
| October 16, 2025 Filed Oct 20, 2025 21:31 UTC |
Nolan Philip ODirector
|
GrantRestricted Stock Units · Derivative | 338 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001369304-25-000005 · wk-form4_1760995861.xml · derivative · entry 1 Nolan Philip O · CIK 0001369304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338 Underlying: CACI Common Stock · 338 shares Expires not disclosed F1 · derivative.exercise_price: On October 16, 2025, Mr. Nolan was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · price: On October 16, 2025, Mr. Nolan was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.exercise_date: On October 16, 2025, Mr. Nolan was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.expiration_date: On October 16, 2025, Mr. Nolan was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| October 16, 2025 Filed Oct 20, 2025 21:30 UTC |
Sloane Stanton DDirector
|
GrantRestricted Stock Units · Derivative | 338 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001291899-25-000005 · wk-form4_1760995849.xml · derivative · entry 1 Sloane Stanton D · CIK 0001291899 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338 Underlying: CACI Common Stock · 338 shares Expires not disclosed F1 · derivative.exercise_price: On October 16, 2025, Mr. Sloane was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · price: On October 16, 2025, Mr. Sloane was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.exercise_date: On October 16, 2025, Mr. Sloane was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.expiration_date: On October 16, 2025, Mr. Sloane was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| October 16, 2025 Filed Oct 20, 2025 21:30 UTC |
SZEWS CHARLES LDirector
|
GrantRestricted Stock Units · Derivative | 338 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001230604-25-000004 · wk-form4_1760995843.xml · derivative · entry 1 SZEWS CHARLES L · CIK 0001230604 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338 Underlying: CACI Common Stock · 338 shares Expires not disclosed F1 · derivative.exercise_price: On October 16, 2025, Mr. Szews was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · price: On October 16, 2025, Mr. Szews was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.exercise_date: On October 16, 2025, Mr. Szews was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.expiration_date: On October 16, 2025, Mr. Szews was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| October 16, 2025 Filed Oct 20, 2025 21:30 UTC |
McCarthy Ryan DDirector
|
GrantRestricted Stock Units · Derivative | 338 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001895585-25-000005 · wk-form4_1760995837.xml · derivative · entry 1 McCarthy Ryan D · CIK 0001895585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338 Underlying: CACI Common Stock · 338 shares Expires not disclosed F1 · derivative.exercise_price: On October 16, 2025, Mr. McCarthy was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · price: On October 16, 2025, Mr. McCarthy was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.exercise_date: On October 16, 2025, Mr. McCarthy was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.expiration_date: On October 16, 2025, Mr. McCarthy was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| October 12, 2025 Filed Oct 14, 2025 21:24 UTC |
Nolan Philip ODirector
|
Exercise / conversionRestricted Stock Units · Derivative | 83 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001369304-25-000004 · wk-form4_1760477063.xml · derivative · entry 2 Nolan Philip O · CIK 0001369304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: CACI Common Stock · 83 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On October 17, 2024, Mr. Nolan was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · price: On October 17, 2024, Mr. Nolan was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · derivative.exercise_date: On October 17, 2024, Mr. Nolan was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · derivative.expiration_date: On October 17, 2024, Mr. Nolan was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. Read SEC document |
| October 12, 2025 Filed Oct 14, 2025 21:24 UTC |
Nolan Philip ODirector
|
Exercise / conversionCACI Common Stock | 83 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001369304-25-000004 · wk-form4_1760477063.xml · nonDerivative · entry 1 Nolan Philip O · CIK 0001369304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,069 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On October 17, 2024, Mr. Nolan was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. Read SEC document |
| October 12, 2025 Filed Oct 14, 2025 21:24 UTC |
Sloane Stanton DDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 83 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001291899-25-000004 · wk-form4_1760477058.xml · derivative · entry 2 Sloane Stanton D · CIK 0001291899 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: CACI Common Stock · 83 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On October 17, 2024, Mr. Sloane was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · price: On October 17, 2024, Mr. Sloane was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · derivative.exercise_date: On October 17, 2024, Mr. Sloane was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · derivative.expiration_date: On October 17, 2024, Mr. Sloane was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. Read SEC document |
| October 12, 2025 Filed Oct 14, 2025 21:24 UTC |
Sloane Stanton DDirector
|
Exercise / conversionCACI Common Stock | 83 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001291899-25-000004 · wk-form4_1760477058.xml · nonDerivative · entry 1 Sloane Stanton D · CIK 0001291899 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On October 17, 2024, Mr. Sloane was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. Read SEC document |
| October 12, 2025 Filed Oct 14, 2025 21:24 UTC |
Plunkett Debora ADirector
|
Exercise / conversionRestricted Stock Units · Derivative | 83 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001699997-25-000004 · wk-form4_1760477048.xml · derivative · entry 2 Plunkett Debora A · CIK 0001699997 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: CACI Common Stock · 83 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On October 17, 2024, Ms. Plunkett was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · price: On October 17, 2024, Ms. Plunkett was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · derivative.exercise_date: On October 17, 2024, Ms. Plunkett was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · derivative.expiration_date: On October 17, 2024, Ms. Plunkett was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. Read SEC document |
| October 12, 2025 Filed Oct 14, 2025 21:24 UTC |
Plunkett Debora ADirector
|
Exercise / conversionCACI Common Stock | 83 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001699997-25-000004 · wk-form4_1760477048.xml · nonDerivative · entry 1 Plunkett Debora A · CIK 0001699997 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On October 17, 2024, Ms. Plunkett was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. Read SEC document |
| October 12, 2025 Filed Oct 14, 2025 21:24 UTC |
MORRISON SCOTT CDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 83 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001205945-25-000005 · wk-form4_1760477039.xml · derivative · entry 2 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: CACI Common Stock · 83 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · price: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · derivative.exercise_date: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · derivative.expiration_date: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. Read SEC document |
| October 12, 2025 Filed Oct 14, 2025 21:24 UTC |
MORRISON SCOTT CDirector
|
Exercise / conversionCACI Common Stock | 83 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001205945-25-000005 · wk-form4_1760477039.xml · nonDerivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. Read SEC document |
| October 12, 2025 Filed Oct 14, 2025 21:24 UTC |
McCarthy Ryan DDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 83 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001895585-25-000004 · wk-form4_1760477044.xml · derivative · entry 2 McCarthy Ryan D · CIK 0001895585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: CACI Common Stock · 83 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On October 17, 2024, Mr. McCarthy was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · price: On October 17, 2024, Mr. McCarthy was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · derivative.exercise_date: On October 17, 2024, Mr. McCarthy was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · derivative.expiration_date: On October 17, 2024, Mr. McCarthy was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. Read SEC document |
| October 12, 2025 Filed Oct 14, 2025 21:24 UTC |
McCarthy Ryan DDirector
|
Exercise / conversionCACI Common Stock | 83 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001895585-25-000004 · wk-form4_1760477044.xml · nonDerivative · entry 1 McCarthy Ryan D · CIK 0001895585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,069 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On October 17, 2024, Mr. McCarthy was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.